咳補助デバイス市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、送達方法の選択肢別、エンドユーザー別、地域別、市場競合別、2020-2030年

咳補助デバイスの世界市場規模は2024年に29億8,000万米ドル、2030年には45億5,000万米ドルに達し、予測期間中のCAGRは7.45％で拡大すると予測されています。

呼吸器の健康に対する意識の高まり、ALSや筋ジストロフィーなどの慢性呼吸器疾患の有病率の増加が市場を牽引しています。咳補助デバイスは、機械的気腹-人工呼吸システムとしても知られ、神経筋障害や脊髄損傷により効果的な咳ができない患者を支援するために使用されます。これらの装置は、気道分泌物を除去するための非侵襲的な方法を提供し、感染症や入院のリスクを低減します。慢性疾患の診断の増加、世界人口の高齢化、在宅ケアへのシフトが市場成長の主な要因です。さらに、携帯性、使いやすさ、スマートな接続機能といった機器設計の進歩により、施設と在宅ケアの両方の環境でのアクセスと採用が拡大しています。しかし、低所得地域では機器コストが高く、アクセスが限られていることが、市場浸透の課題となっています。とはいえ、ヘルスケアインフラへの継続的な投資、製品イノベーション、呼吸ケア意識の向上により、特に新興経済圏では市場の勢いが維持されると予想されます。

市場促進要因

慢性呼吸器疾患の増加

主な市場課題

デバイスの高コスト

主要市場動向

技術の進歩とAIの統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の咳補助デバイス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（自動vs手動）
  • 配送方法の選択（フェイスマスク、マウスピース、アダプター）
  • エンドユーザー別（病院・診療所、外来診療所、在宅ケア、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • タイプ別
  • 配送方法の選択
  • エンドユーザー別
  • 地域別

第6章 北米の咳補助デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の咳補助デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の咳補助デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の咳補助デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの咳補助デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 競合情勢

• Koninklijke Philips N.V.
• Hillrom Holdings, Inc.
• Percussionaire Corp.
• Dima Italia Srl
• United Hayek Industries Inc
• McKesson Medical-Surgical Inc.
• Aetna Inc.
• International Biophysics Corporation
• PARI GmbH
• Air Liquide Medical Systems S.A.

第14章 戦略的提言

第15章 調査会社について・免責事項

The Global Cough Assist Devices Market was valued at USD 2.98 billion in 2024 and is projected to reach USD 4.55 billion by 2030, expanding at a CAGR of 7.45% during the forecast period. The market is being driven by rising awareness around respiratory health and a growing prevalence of chronic respiratory illnesses such as ALS and muscular dystrophy. Cough assist devices, also known as mechanical insufflation-exsufflation systems, are used to assist patients who cannot cough effectively due to neuromuscular disorders or spinal cord injuries. These devices provide a non-invasive method for clearing airway secretions, reducing the risk of infections and hospitalizations. Increasing diagnosis of chronic conditions, an aging global population, and the shift toward home-based care are major factors contributing to market growth. Furthermore, advancements in device design-such as portability, ease of use, and smart connectivity features-are expanding access and adoption across both institutional and homecare settings. However, high equipment costs and limited access in lower-income regions continue to challenge market penetration. Nonetheless, ongoing investments in healthcare infrastructure, product innovation, and respiratory care awareness are expected to sustain market momentum, particularly in emerging economies.

Key Market Drivers

Rising prevalence of chronic respiratory diseases

The increasing incidence of chronic respiratory disorders is a key driver for the global cough assist devices market. Conditions such as COPD, asthma, bronchiectasis, and neuromuscular diseases-including ALS and muscular dystrophy-impair the ability to clear airway secretions. For patients with weakened respiratory muscles, natural coughing becomes ineffective, making cough assist devices vital for secretion clearance and infection prevention. Factors such as air pollution, smoking, and occupational exposures are accelerating the burden of respiratory diseases, particularly in low- and middle-income countries. The rise in global life expectancy is also contributing to a larger elderly population at higher risk for respiratory complications. As healthcare providers prioritize early diagnosis and preventative care, there is a growing emphasis on integrating cough assist devices into long-term treatment plans. These devices are increasingly recommended to improve patient outcomes, reduce hospital visits, and support quality of life for those living with chronic respiratory conditions. This trend is especially significant in the homecare segment, where long-term respiratory support is essential.

Key Market Challenges

High cost of devices

The high cost associated with cough assist devices is a major constraint for market expansion. These devices entail significant upfront investment, in addition to recurring expenses related to accessories, servicing, and user training. For many patients-particularly in developing regions-the cost barrier prevents access to these crucial respiratory support tools. Reimbursement policies for such devices remain inconsistent across markets, further exacerbating out-of-pocket expenses for users. Limited funding and insurance coverage often discourage healthcare professionals from prescribing these devices, knowing that affordability may be an issue for patients. In homecare settings, this financial burden typically falls on families or caregivers, creating additional reluctance to invest in the technology. While innovations in design and features continue, they often raise production costs, which manufacturers then pass on to consumers. This pricing dynamic complicates efforts to scale adoption. Solutions such as expanded reimbursement, targeted subsidies, and the development of more affordable alternatives are needed to overcome this barrier and enhance access to life-improving respiratory devices.

Key Market Trends

Technological Advancements and AI Integration

The market is being reshaped by technological advancements and the integration of artificial intelligence (AI) into cough assist devices. Newer models feature compact, portable designs, improved pressure modulation, and user-friendly interfaces that make them more comfortable and efficient for daily use. AI-powered functionalities allow these devices to analyze cough patterns and respiratory metrics, aiding in the early diagnosis and monitoring of conditions like COPD and pneumonia. Real-time data collection and predictive analytics enable more precise, individualized treatment planning. Furthermore, smart connectivity features allow remote monitoring by healthcare professionals, enhancing continuity of care and minimizing hospital visits. These innovations are particularly beneficial in homecare environments, where constant clinical supervision is not feasible. Digital platforms also foster better communication among patients, caregivers, and medical teams, contributing to improved compliance and outcomes. As AI and smart features become more widespread, cough assist devices are expected to become increasingly personalized, adaptable, and aligned with the broader trend toward connected health ecosystems.

Key Market Players

• Koninklijke Philips N.V.
• Hillrom Holdings, Inc.
• Percussionaire Corp.
• Dima Italia Srl
• United Hayek Industries Inc
• McKesson Medical-Surgical Inc.
• Aetna Inc.
• International Biophysics Corporation
• PARI GmbH
• Air Liquide Medical Systems S.A.

Report Scope:

In this report, the Global Cough Assist Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cough Assist Devices Market, By Type:

• Automatic
• Manual

Cough Assist Devices Market, By Choice of Deliver:

• Face Mask
• Mouthpiece
• Adapter

Cough Assist Devices Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Settings
• Homecare
• Others

Cough Assist Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cough Assist Devices Market.

Available Customizations:

Global Cough Assist Devices Market report with the given Market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cough Assist Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Automatic v/s Manual)
  • 5.2.2. By Choice of Delivery (Face Mask, Mouthpiece, Adapter)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Settings, Homecare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Choice of Delivery
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Cough Assist Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Choice of Delivery
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cough Assist Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Choice of Delivery
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Cough Assist Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Choice of Delivery
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Cough Assist Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Choice of Delivery
      • 6.3.3.2.3. By End User

7. Europe Cough Assist Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Choice of Delivery
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cough Assist Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Choice of Delivery
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Cough Assist Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Choice of Delivery
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Cough Assist Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Choice of Delivery
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Cough Assist Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Choice of Delivery
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Cough Assist Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Choice of Delivery
      • 7.3.5.2.3. By End User

8. Asia-Pacific Cough Assist Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Choice of Delivery
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cough Assist Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Choice of Delivery
      • 8.3.1.2.3. By End User
  • 8.3.2. India Cough Assist Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Choice of Delivery
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Cough Assist Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Choice of Delivery
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Cough Assist Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Choice of Delivery
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Cough Assist Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Choice of Delivery
      • 8.3.5.2.3. By End User

9. South America Cough Assist Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Choice of Delivery
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cough Assist Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Choice of Delivery
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Cough Assist Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Choice of Delivery
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Cough Assist Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Choice of Delivery
      • 9.3.3.2.3. By End User

10. Middle East and Africa Cough Assist Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Choice of Delivery
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cough Assist Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Choice of Delivery
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Cough Assist Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Choice of Delivery
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Cough Assist Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Choice of Delivery
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Koninklijke Philips N.V.
  • 13.1.1. Business Overview
  • 13.1.2. Company Snapshot
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Recent Developments
  • 13.1.6. SWOT Analysis
• 13.2. Hillrom Holdings, Inc.
• 13.3. Percussionaire Corp.
• 13.4. Dima Italia Srl
• 13.5. United Hayek Industries Inc
• 13.6. McKesson Medical-Surgical Inc.
• 13.7. Aetna Inc.
• 13.8. International Biophysics Corporation
• 13.9. PARI GmbH
• 13.10. Air Liquide Medical Systems S.A.

14. Strategic Recommendations

15. About Us & DIsclaimer